These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 34225642

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD, Thompson DS.
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Case report: psychosis with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    de Rego JA, Goldstein DM.
    Hillside J Clin Psychiatry; 1985 Sep; 7(2):141-8. PubMed ID: 4077031
    [Abstract] [Full Text] [Related]

  • 5. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
    Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schröder W, Roujeau JC, SCAR Study Group. Severe Cutaneous Adverse Reactions.
    Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
    [Abstract] [Full Text] [Related]

  • 6. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N, Elmrahi A, Dikhaye S, Fihmi N, Alami Z.
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [Abstract] [Full Text] [Related]

  • 7. Stevens-Johnson syndrome-toxic epidermal necrolysis overlap in a patient taking quetiapine and famotidine: a case report.
    Su CS, Kao CL.
    J Med Case Rep; 2024 Jul 28; 18(1):344. PubMed ID: 39068499
    [Abstract] [Full Text] [Related]

  • 8. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L, Lee L, Weaver J, Bonnel R, Karwoski C, Governale L, Brinker A.
    Drug Saf; 2005 Jul 28; 28(10):917-24. PubMed ID: 16180941
    [Abstract] [Full Text] [Related]

  • 9. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E, Köse O, Erbil AH, Nişanci M, Akar A, Gür AR.
    Pediatr Dermatol; 2005 Jul 28; 22(4):317-20. PubMed ID: 16060867
    [Abstract] [Full Text] [Related]

  • 10. Incidence of Stevens-Johnson syndrome following combination drug use of allopurinol, carbamazepine and phenytoin in Taiwan: A case-control study.
    Syu FK, Pan HY, Chuang PC, Huang YS, Cheng CY, Cheng FJ.
    J Dermatol; 2018 Sep 28; 45(9):1080-1087. PubMed ID: 29963717
    [Abstract] [Full Text] [Related]

  • 11. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N, Bastuji-Garin S, Mockenhaupt M, Roujeau JC, Flahault A, Kelly JP, Martin E, Kaufman DW, Maison P.
    Pediatrics; 2009 Feb 28; 123(2):e297-304. PubMed ID: 19153164
    [Abstract] [Full Text] [Related]

  • 12. Retrospective review of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis cases at a pediatric tertiary care institution.
    Sibbald C, Putterman E, Micheletti R, Treat J, Castelo-Soccio L.
    Pediatr Dermatol; 2020 May 28; 37(3):461-466. PubMed ID: 32058621
    [Abstract] [Full Text] [Related]

  • 13. Cephalexin induced toxic epidermal necrolysis.
    Dave J, Heathcock R, Fenelon L, Bihari DJ, Simmons NA.
    J Antimicrob Chemother; 1991 Sep 28; 28(3):477-8. PubMed ID: 1960132
    [No Abstract] [Full Text] [Related]

  • 14. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.
    Power WJ, Ghoraishi M, Merayo-Lloves J, Neves RA, Foster CS.
    Ophthalmology; 1995 Nov 28; 102(11):1669-76. PubMed ID: 9098260
    [Abstract] [Full Text] [Related]

  • 15. Causative Drugs of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Israel.
    Maggio N, Firer M, Zaid H, Bederovsky Y, Aboukaoud M, Gandelman-Marton R, Noyman I, Ekstein D, Blatt I, Marom E, Schwartzberg E, Israel S, Ingber A, Brautbar C, Eyal S.
    J Clin Pharmacol; 2017 Jul 28; 57(7):823-829. PubMed ID: 28181259
    [No Abstract] [Full Text] [Related]

  • 16. Toxic epidermal necrolysis due to cephalexin.
    Hogan DJ, Rooney ME.
    J Am Acad Dermatol; 1987 Nov 28; 17(5 Pt 1):852-3. PubMed ID: 3680666
    [No Abstract] [Full Text] [Related]

  • 17. Phenytoin-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Overlap in Focus: A Case Report.
    Puri P, Aslam ZM, Komal F, Prachi F, Sardana P, Chitkara A.
    Cureus; 2023 Sep 28; 15(9):e46075. PubMed ID: 37900419
    [Abstract] [Full Text] [Related]

  • 18. Recurrent blisters in a case of resolving Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Chuang YN, Ho YY, Chiu TM.
    Indian J Dermatol Venereol Leprol; 2014 Sep 28; 80(6):546-7. PubMed ID: 25382518
    [No Abstract] [Full Text] [Related]

  • 19. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.
    Frey N, Bodmer M, Bircher A, Jick SS, Meier CR, Spoendlin J.
    Drug Saf; 2019 Jan 28; 42(1):55-66. PubMed ID: 30112729
    [Abstract] [Full Text] [Related]

  • 20. Stevens-Johnson Syndrome/Toxic epidermal necrolysis complicated with fulminant type 1 diabetes mellitus: a case report and literature review.
    Zhang X, Huang D, Lou D, Si X, Mao J.
    BMC Endocr Disord; 2024 Sep 02; 24(1):172. PubMed ID: 39218880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.